LATANOPROST SANDOZ 50mcg/ml ophthalmic drops solution
Active substance: latanoprost
S01EE01 Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Indicated for: glaucoma; ocular hypertension
Find medicines for human use by name or active substance.
Browse by initial
181–200 of 1,082 medicines
Active substance: latanoprost
S01EE01 Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Indicated for: glaucoma; ocular hypertension
Active substance: latanoprost
S01EE01 Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Indicated for: glaucoma; ocular hypertension
Active substance: latanoprost + timolol
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; ocular hypertension
Active substance: latanoprost + timolol
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; ocular hypertension
Active substance: latanoprost + timolol
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; ocular hypertension
Active substance: latanoprost + timolol
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; ocular hypertension
Active substance: latanoprost + timolol
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
Indicated for: glaucoma; ocular hypertension
Active substance: imatinib
Indicated for: chronic myeloid leukemia; gastrointestinal stromal tumors
Active substance: imatinib
Indicated for: chronic myeloid leukemia; gastrointestinal stromal tumors
Active substance: ranolazine
C01EB18 Cardiovascular system | Other cardiac preparations
Indicated for: angina pectoris
Active substance: ranolazine
C01EB18 Cardiovascular system | Other cardiac preparations
Indicated for: angina pectoris
Active substance: ranolazine
C01EB18 Cardiovascular system | Other cardiac preparations
Indicated for: angina pectoris
Active substance: lurasidone
N05AE05 Nervous system | Antipsychotics | Indole derivatives
Indicated for: schizophrenia; bipolar disorder
Active substance: lurasidone
N05AE05 Nervous system | Antipsychotics | Indole derivatives
Indicated for: schizophrenia; bipolar disorder
Active substance: lurasidone
N05AE05 Nervous system | Antipsychotics | Indole derivatives
Indicated for: schizophrenia; bipolar disorder
Active substance: bisacodyl
Indicated for: constipation
Active substance: lazertinib
Indicated for: non-small cell lung cancer
Active substance: lazertinib
Indicated for: non-small cell lung cancer
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.